CB

Caleb Bell III

Human looking to facilitate the transition to humanity 2.0

Cambridge, Massachusetts

Invests in

Stages:

Locations:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Skills

making things happen
Biotechnology
Life Sciences
Molecular Biology
Entrepreneurship
Start-ups
Fundraising
Cooking
Spectroscopy
Lifesciences
Cell
Biochemistry
Chemistry
Organic Chemistry
Drug Discovery
Genetics
Cell Biology
Science
Cancer
Genomics

Education

Work Experience

  • Investment Committee Microbiome/Life Science

    2024

    CE-Ventures, the corporate venture capital platform of Crescent Enterprises, targets deep tech companies from Series A onwards, operating in range of verticals (life sciences, microbiome, healthtech, enterprise software, fintech, niche consumer-focused, and emerging technologies). CE-Ventures looks to partner with incredible fund managers and startups in the US, MENA, India and South-East Asia. Moreover, CE-Ventures supports growing the tech ecosystem in the Middle-East by both supporting local entrepreneurs to expand across GCC and bringing their global portfolio companies to UAE. They leverage their strong global network for their portfolio companies to assist them across all business areas— PR, recruitment, market insights, fund-raising and business development.

Corundum Convergence Institute

2023

  • Founding President and Executive Director

    2023

    A US based 501(c)(3) non profit with the mission to enhance the quality of human lives by advancing ground-breaking research, pioneering breakthroughs, and pushing the boundaries of possibilities in the fields of neuroscience, systems biology and Artificial Intelligence (AI) for scientific discoveries. We are committed to driving applicable / translational science through funding and fostering of interdisciplinary collaborations to help transform theoretical insights into tangible solutions that positively impact individuals and society.

  • Venture Partner

    2022

    To serve as the Innovation-Hub where the world’s best knowledge and intelligence on life science research is assembled to create innovations for the future of the human race through the approach that perceives the complexity of the human body as a system. Further, to revitalize Japan through creation of new industries as the Hub to connect Japan’s industry-academia-government activities, conducted in the hope of becoming the scientific and technological nation, with global innovation eco-systems.

  • Advisor

    2023

  • Venture Partner

    2018 - 2023

    Beyond Next Ventures believes in the potential of Japanese science and technology. Our core mission is to grow and harness the potential of motivated entrepreneurs with revolutionary technology, and commercialize their ideas to help build a better future and society. We focus on fostering an environment that stimulates maximum productivity.

  • Advisor

    2019

2022 - 2023

  • Advisor

    2022 - 2023

  • Managing Director

    2022 - 2022

    CTIC Capital is a global boutique financial firm focusing on life sciences, biotech and healthcare. With offices in Silicon Valley, Chicago, Boston and Hong Kong we leverage our trans-pacific networks and local expertise in multiple ecosystems to support small and large, US and Asian enterprises in venture financings, M&A, and strategic partnerships.

  • Advisor

    2022 - 2023

2021 - 2022

  • Team Member

    2022 - 2022

  • Board of Directors

    2021 - 2021

2018 - 2022

  • Advisor

    2018 - 2022

Argonaut genomics

2020 - 2022

  • Advisor

    2020 - 2022